According to an estimate by the American Heart Association (AHA), the annual US medical costs for cardiovascular diseases are likely to increase to over USD 800 billion in 2030, which is nearly triple the amount spent in 2010 (USD 272 billion) [2]
With obesity being a primary risk factor for type 2 diabetes, cardiovascular diseases, and several cancers, healthcare systems are increasingly recognizing it as a disease that warrants pharmacological intervention
This later onset compared to sweet cravings may reflect different neurological mechanisms for salt preference versus sugar preference
Combine zone 2 cardio with resistance training for optimal results
Everyone has different needs that should be considered
Brett Osborn, a Florida neurologist and longevity expert, agreed that the availability of the first generic GLP-1 is "great news." The generics lower price point is particularly beneficial for people who have chronic conditions like diabetes, Osborn noted "where long-term medication use is necessary to prevent downrange effects like vascular disease, strokes and heart attacks , cancer, neurodegenerative diseases like Alzheimers, and obesity, the latter of which is also a gateway disease," he said